Patient Capital Management, LLC Bausch Health Companies Inc. Transaction History

Patient Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.58 - $9.21 $997,982 - $2.01 Million	-217,900 Reduced 53.74%	187,600 $1.29 Million
Q2 2022 Aug 15, 2022	BUY	$7.06 - $23.63 $947,452 - $3.17 Million	134,200 Added 49.47%	405,500 $3.39 Million
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $410,400 - $528,010	-19,000 Reduced 6.54%	271,300 $6.2 Million
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $6.68 Million - $8.42 Million	290,300 New	290,300 $8.02 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Patient Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Patient Capital Management, LLC with notifications on news.